Last checked at 3 Apr 2023 09:27
Hikma Pharmaceuticals PLC
Block Listing Six Monthly Return
Date: 3 April 2023
Name of applicant: | Hikma Pharmaceuticals PLC | ||
Name of scheme: | Hikma Pharmaceuticals PLC 2004 Stock Option Plan ("SOP")
| ||
Period of return | From: 1 October 2022 | To: | 31 March 2023 |
Balance of unallotted securities under scheme(s) from previous return: | SOP: 792,700 Ordinary Shares of 10 pence | ||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | SOP: 0 Ordinary Shares of 10 pence | ||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | SOP: 0 Ordinary Shares of 10 pence | ||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: | SOP: 792,700 Ordinary Shares of 10 pence | ||
The Hikma Pharmaceuticals plc 2004 Stock Option Plan has expired. No further shares may be issued under the block listing and no further block listing returns will be made in respect of this expired Plan; therefore, the block listing is hereby cancelled. In accordance with LR3.5.6R, a final block listing return in respect of this block listing is set out above in the prescribed form. | |||
Name of contact: | Hussein Arkhagha |
Telephone number of contact: | +44(0)20 7399 2760 |
Block Listing Six Monthly Return
Date: 3 April 2023
Name of applicant: | Hikma Pharmaceuticals PLC | ||
Name of scheme: | Hikma Pharmaceuticals PLC 2005 Long-Term Incentive Plan ("LTIP") | ||
Period of return | From: 1 October 2022 | To: | 31 March 2023 |
Balance of unallotted securities under scheme(s) from previous return: | LTIP: 57,502 Ordinary Shares of 10 pence | ||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | LTIP: 0 Ordinary Shares of 10 pence | ||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | LTIP: 0 Ordinary Shares of 10 pence | ||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: | LTIP: 57,502 Ordinary Shares of 10 pence | ||
The Hikma Pharmaceuticals plc 2005 Long-Term Incentive Plan has expired. No further shares may be issued under the block listing and no further block listing returns will be made in respect of this expired Plan; therefore, the block listing is hereby cancelled. In accordance with LR3.5.6R, a final block listing return in respect of this block listing is set out above in the prescribed form. | |||
Name of contact: | Hussein Arkhagha |
Telephone number of contact: | +44(0)20 7399 2760 |
Block Listing Six Monthly Return
Date: 3 April 2023
Name of applicant: | Hikma Pharmaceuticals PLC | ||
Name of scheme: | Hikma Pharmaceuticals PLC 2009 Management Incentive Plan ("2009 MIP") | ||
Period of return | From: 1 October 2022 | To: | 31 March 2023 |
Balance of unallotted securities under scheme(s) from previous return: | 2009 MIP: 0 Ordinary Shares of 10 pence | ||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 2009 MIP: 0 Ordinary Shares of 10 pence | ||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 2009 MIP: 0 Ordinary Shares of 10 pence | ||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 2009 MIP: 0 Ordinary Shares of 10 pence | ||
The Hikma Pharmaceuticals plc 2009 Management Incentive Plan has expired. No further shares may be issued under the block listing and no further block listing returns will be made in respect of this expired Plan; therefore, the block listing is hereby cancelled. In accordance with LR3.5.6R, a final block listing return in respect of this block listing is set out above in the prescribed form. | |||
Name of contact: | Hussein Arkhagha |
Telephone number of contact: | +44(0)20 7399 2760 |
Block Listing Six Monthly Return
Date: 3 April 2023
Name of applicant: | Hikma Pharmaceuticals PLC | ||
Name of scheme: | Hikma Pharmaceuticals PLC 2018 Management Incentive Plan ("2018 MIP") and Hikma Pharmaceuticals PLC 2014 Executive Incentive Plan ("EIP") (together "the Plans") | ||
Period of return | From: 1 October 2022 | To: | 31 March 2023 |
Balance of unallotted securities under scheme(s) from previous return: | 2018 MIP: 414,112 Ordinary Shares of 10 pence EIP: 354,962 Ordinary Shares of 10 pence | ||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | The Plans: 1,200,000 Ordinary Shares of 10 pence | ||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 2018 MIP: 294,737 Ordinary Shares of 10 pence EIP: 176,424 Ordinary Shares of 10 pence | ||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: | The Plans: 1,497,913 Ordinary Shares of 10 pence | ||
Name of contact: | Hussein Arkhagha |
Telephone number of contact: | +44(0)20 7399 2760 |
LEI: 549300BNS685UXH4JI75